John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
Amazon
AMZN
|
+$243M |
| 3 |
Applied Materials
AMAT
|
+$242M |
| 4 |
Airbnb
ABNB
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$262M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$259M |
| 3 |
Wells Fargo
WFC
|
+$238M |
| 4 |
Broadcom
AVGO
|
+$233M |
| 5 |
Applovin
APP
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.95% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
ArcelorMittal
MT
$54.4B
| $32.9M | 0.07% |
1,422,563
-363,669
| -20% | -$8.97M |
|
327
Estee Lauder
EL
$36.9B
| $32.7M | 0.07% |
436,457
-1,798,864
| -80% | -$142M |
|
328
Tenet Healthcare
THC
$22.6B
| $32.6M | 0.07% |
257,943
+147,731
| +134% | +$22M |
|
329
Equifax
EFX
$22.6B
| $32.3M | 0.07% |
126,877
-29,945
| -19% | -$8.02M |
|
330
Ionis Pharmaceuticals
IONS
$9.93B
| $32.2M | 0.07% |
921,439
+2,362
| +0.3% | +$88.3K |
|
331
Datadog
DDOG
$84.6B
| $32.1M | 0.07% |
224,381
-216,239
| -49% | -$29.7M |
|
332
Kohl's
KSS
$2B
| $31.7M | 0.07% |
2,255,480
+87,235
| +4% | +$1.5M |
|
333
Teradyne
TER
$58.7B
| $31.6M | 0.07% |
250,702
+75,257
| +43% | +$8.91M |
|
334
Allegro MicroSystems
ALGM
$6.93B
| $31.4M | 0.07% |
1,434,188
+54,485
| +4% | +$1.16M |
|
|
BA.PRA
335
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$7.63B
| $31.2M | 0.07% |
+512,732
| New | +$28.9M |
|
336
FMC
FMC
$1.38B
| $31.1M | 0.07% |
639,989
-140,788
| -18% | -$8.22M |
|
337
Tandem Diabetes Care
TNDM
$1.55B
| $31M | 0.07% |
861,188
+36,475
| +4% | +$1.23M |
|
338
iShares Biotechnology ETF
IBB
$10.7B
| $31M | 0.07% |
234,607
-49,600
| -17% | -$6.97M |
|
339
Elastic
ESTC
$8.93B
| $30.7M | 0.07% |
309,766
+273,134
| +746% | +$25.2M |
|
340
Bruker
BRKR
$9.07B
| $30.3M | 0.07% |
516,232
+291,313
| +130% | +$17.2M |
|
341
Duolingo
DUOL
$6.84B
| $30.2M | 0.07% |
93,047
-57,435
| -38% | -$18.3M |
|
|
PPL
342
PUT
PPL Corp
PPL
$25.9B
| $30M | 0.07% |
925,700
| – | – |
|
343
British American Tobacco
BTI
$121B
| $29.9M | 0.07% |
823,753
-297,048
| -27% | -$10.7M |
|
344
Vanguard Health Care ETF
VHT
$19.7B
| $29.9M | 0.07% |
117,700
+84,600
| +256% | +$22.8M |
|
345
Virtu Financial
VIRT
$6B
| $29.8M | 0.06% |
834,400
+73,304
| +10% | +$2.52M |
|
346
Cellebrite
CLBT
$2.77B
| $29.7M | 0.06% |
1,349,659
-227,733
| -14% | -$4.38M |
|
347
Bank OZK
OZK
$5.39B
| $29.7M | 0.06% |
666,594
-296,806
| -31% | -$13.6M |
|
348
Ovintiv
OVV
$18.5B
| $29.7M | 0.06% |
732,511
-397,783
| -35% | -$16.6M |
|
349
Cenovus Energy
CVE
$60.7B
| $29.6M | 0.06% |
1,957,007
+1,079,098
| +123% | +$17.4M |
|
350
PTC
PTC
$16.8B
| $29.5M | 0.06% |
160,379
+35,928
| +29% | +$6.81M |
|
Similar funds
John Overdeck's Q4 2024 Portfolio in Review
As of Q4 2024, John Overdeck held 3,590 positions worth $45.9B, up 0.48% from $45.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $1.69B in Q4 2024, closing 427 positions and reducing 1,388 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Intel worth $237M.
- John Overdeck's largest Q4 2024 buy was Intel: 11,843,258 shares worth $237M.
- John Overdeck added most to Amazon in Q4 2024, an estimated $243M increase.
- John Overdeck's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $262M.
- John Overdeck fully exited iShares MSCI Emerging Markets ETF in Q4 2024, selling an estimated $184M.
- John Overdeck's ten largest holdings make up 7.2% of its $45.9B portfolio in Q4 2024.
- John Overdeck opened 477 new positions and closed 427 in Q4 2024.
- John Overdeck's portfolio value rose 0.48% quarter-over-quarter to $45.9B.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.